Long-term inflammatory and neoplastic reaction of prostate tissues during its transurethral infection with uropathogens: evaluation of the results of animal model study
- Authors: Kogan M.I1, Ismailov R.S1, Todorov S.S1, Naboka Y.L1, Gudima I.A1
-
Affiliations:
- Rostov State Medical University
- Issue: No 5 (2022)
- Pages: 5-14
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277061
- DOI: https://doi.org/10.18565/urology.2022.5.5-14
- ID: 277061
Cite item
Abstract
Keywords
Full Text
About the authors
M. I Kogan
Rostov State Medical University
Email: dept_kogan@mail.ru
Honored Scientist of the Russian Federation, M.D., Dr.Sc. (Med), Full Prof.; Head, Dept. of Urology and Human Reproductive Health (with the Pediatric Urology and Andrology Course) Rostov-on-Don, Russia
R. S Ismailov
Rostov State Medical University
Email: dr.ruslan.ismailov@gmail.com
M.D., Cand.Sc. (Med); Assist.Prof., Dept. of Urology and Human Reproductive Health (with the Pediatric Urology and Andrology Course) Rostov-on-Don, Russia
S. S Todorov
Rostov State Medical University
Email: sertodorov@gmail.com
M.D., Dr.Sc. (Med); Prof., Dept. of Pathology, Rostov State Medical University; Head, Morphology Division, Rostov State Medical University Clinic Rostov-on-Don, Russia
Yu. L Naboka
Rostov State Medical University
Email: nagu22@mail.ru
M.D., Dr.Sc. (Med), Full Prof.; Head, Dept. of Microbiology and Virology № 1 Rostov-on-Don, Russia
I. A Gudima
Rostov State Medical University
Email: naguirina22@gmail.com
M.D., Dr.Sc. (Med), Assoc. Prof.; Prof., Dept. of Microbiology and Virology № 1 Rostov-on-Don, Russia
References
- Коган М.И., Набока Ю.Л., Тодоров С.С., Исмаилов Р.С. Экспериментальная оценка течения воспалительного процесса в простате при ее трансуретральном инфицировании низким титром уропатогена. Урология. 2019;5:14-21.Doi: 10.18565/ urology.2019.5.14-21.
- Коган М.И., Набока Ю.Л., Тодоров С.С., Исмаилов Р.С. Сравнительная оценка развития и течения воспалительного процесса в простате при трансуретральном инфицировании с использованием каузативного и дебатируемых штаммов микроорганизмов в низких титрах. Экспериментальная и клиническая урология. 2019;3:40-48. doi: 10.29188/2222-8543-201911-3-40-48.
- Исмаилов Р.С., Набока Ю.Л., Тодоров С.С., Коган М.И. Связаны ли между собой бактериологические и патоморфологические признаки бактериального простатита? (экспериментальное исследование). Урология. 2020;6:44-52. doi: 10.18565/urology.2020.6.44-51.
- Dennis L.K., Lynch C.F., Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology. 2002;60(1):78-83. Doi: 10.1016/ s0090-4295(02)01637-0.
- Jiang J., Li J., Yunxia Z., Zhu H., Liu J., Pumill C. The role of prostatitis in prostate cancer: meta-analysis. PLoS One. 2013;8( 12) :e85179. doi: 10.1371/journal.pone.0085179.
- Schetter A.J., Heegaard N.H., Harris C.C. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31(1):37-49. doi: 10.1093/carcin/bgp272.
- Lonkar P., Dedon P.C. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates.Int J Cancer. 2011;128(9):1999-2009. doi: 10.1002/ijc.25815.
- Pan JS, Hong MZ, Ren JL. Reactive oxygen species: a double-edged sword in oncogenesis. World J Gastroenterol. 2009; 15( 14): 1702-1707. doi: 10.3748/wjg.15.1702.
- Shen H.M., Tergaonkar V. NF-kappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis. 2009;14(4):348- 363. doi: 10.1007/s10495-009-0315-0.
- Pascal L.E., Wang Y., Zhong M., Wang D., Chakka A.B., Yang Z., Li F., Song Q., Rigatti L.H., Chaparala S., Chandran U., Parwani A.V., Wang Z. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. Neoplasia. 2018;20(4):351-363. doi: 10.1016/j.neo.2018.01.011.
- Bollrath J., Greten F.R. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep. 2009; 10(12):1314-1349. Doi: 10.1038/ embor.2009.243.
- Fisher G., Yang Z.H., Kudahetti S., Moller H., Scardino P., Cuzick J., Berney D.M. Transatlantic Prostate Group. Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort. Br J Cancer. 2013 Feb 5;108(2):271-277. doi: 10.1038/bjc.2012.598. Epub 2013 Jan 17. PMID: 23329234; PMCID: PMC3566811.
- Kudryavtsev GY, Kudryavtseva LV, Mikhaleva LM, Solovieva NA, Babichenko II. Immunohistochemical study of Ki-67, p53 and Notch1 expressions in prostate cancer of different grades. Arkh Patol. 2020;82(5):42-49.Russian. doi: 10.17116/patol20208205142.
- Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of Animals used for Scientific purposes. OJ L 2010;276: 33-79.
- European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS No.123). Appendix A «Guidelines for the maintenance and care of animals». Adopted: Strasbourg, 18.03.1986, entry in force: 01.01.1991. URL: https://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?doc umentId=090000168007a67b
- Mahler M., Berard M., Feinstein R., Gallagher A., Illgen-Wilcke B., Pritchett-Corning K., Raspa M. FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim 2014;48(3); 178-192. doi: 10.1177/0023677213516312
- Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010;8(6): e1000412. Doi: 10.1371/ journal.pbio.1000412.
- Nickel J.C., Olson M.E., Barabas A., Benediktsson H., Dasgupta M.K., Costerton J.W. Pathogenesis of Chronic Bacterial Prostatitis in an animal model. British J of Urol. 1990;66(6): 47-54. Doi: 10.1111/j. 1464-410X.1990.tb14864.x
- Petrescu A., Marzan L., Codreanu O., Niculescu L. Immunohistochemical detection of p53 protein as a prognostic indicator in prostate carcinoma. Rom J Morphol Embryol. 2006;47:143-146.
- Madani S.H., Ameli S., Khazaei S., Kanani M., Izadi B. Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer. Indian J Pathol Microbiol. 2011;54:688-691.
- Kaplan L., Lee C., Schaeffer A.J. Effect of castration on experimental bacterial prostatitis in rats. Prostate. 1983;4(6):625-630. Doi: 10.1002/ pros.2990040608.
- Seo S.I., Lee S.J., Kim J.C., Choi Y.J., S.W.S. W., Hwang T.K., Cho Y.H. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model.Int J Urol. 2003; 10(9):485-491. Doi: 10.1046/j. 1442-2042.2003.00666.x. PMID: 12941127.
- Elkahwaji E., Zhong W., Janda L.M., Bjorling D.E., Bushman W. Chronic prostatic infection and inflammation induce reactive dysplasia and neoplasia in mice. J Urol 2006;175 (Suppl):258.
- Elkahwaji J.E., Ott C.J., Janda L.M., Hopkins W.J. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology. 2005;66(4):883-887. doi: 10.1016/j.urology.2005.04.013.
- Verma R, Gupta V, Singh J, Verma M, Gupta G, Gupta S, Sen R, Ralli M. Significance of p53 and ki-67 expression in prostate cancer. Urol Ann. 2015;7(4):488-493. doi: 10.4103/0974-7796.158507.
- Jiang T., Jiang H., Song X.S., Li X.C., Li Q.L. P53 expression and its clinical significance in prostatic carcinoma. Zhonghua Nan Ke Xue. 2005;11:448-451:454.
- Olivier M., Hainaut P., Borresen-Dale A.L. (2007). Prognostic and Predictive Value of TP53 Mutations in Human Cancer. In: Hainaut, P., Wiman, K.G. (eds) 25 Years of p53 Research. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-2922-6_14
- Bourdon J.C. p53 and its isoforms in cancer. Br J Cancer. 2007;97(3):277- 282. doi: 10.1038/sj.bjc.6603886.
- Wang Y., Abenojar E.C., Wang J., de Leon A.C., Tavri S., Wang X., Gopalakrishnan R., Walker E., MacLennan G.T., Giles A., Czarnota G.J., Basilion J.P., Exner A.A. Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit. Prostate. 2022;82(6):695-705. doi: 10.1002/pros.24314.